Sort
23,748 grants matching “melanoma”
Strategies for Receptor inhibition in immunotherapy
$396,586Kenan Christopher Garcia · Stanford University · R01 · FY2021 · CA
Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles
$396,582Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
DNA Markers As Surrogates:Melanoma Patient Response
$396,578John Wayne Cancer Institute · R33 · FY2005 · CA
Regulation of the ERK signaling pathway by K63-linked polyubiquitination
$396,533Xiaolu Yang · University Of Pennsylvania · R01 · FY2023 · CA
SOUTHWEST ONCOLOGY GROUP
$396,518Swedish Medical Center, First Hill · U10 · FY2001 · CA
Therapeutic resistance and tumor heterogeneity in BRAF mutant colorectal cancer
$396,501Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2018 · CA
Therapeutic resistance and tumor heterogeneity in BRAF mutant colorectal cancer
$396,501Ryan Bruce Corcoran · Massachusetts General Hospital · R01 · FY2020 · CA
Follicular Regulatory T-cells Promote Cancer
$396,483Jianmei Wu Leavenworth · University Of Alabama At Birmingham · R01 · FY2023 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$396,453Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities
$396,432Brent Allen Hanks · Duke University · R01 · FY2021 · CA
Local Immuroregulation of Cutaneous Carcinogenesis
$396,427Michael Girardi · Yale University · R01 · FY2016 · CA
Characterization of JNK in Cell Cycle Control
$396,325Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2008 · CA
Function of ATF2 URE binding protein in human melanoma
$396,325Burnham Institute For Medical Research · R01 · FY2005 · CA
Targeting apoptosis via chemical design of Bcl-2 antagonists
$396,325Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Characterization of JNK in Cell Cycle Control
$396,325Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Generation and utility of NADPH oxidase inhibitors
$396,325Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Characterization of JNK in Cell Cycle Control
$396,325Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2009 · CA
Novel function of MUC18: amplification of inflammation in allergic lungs
$396,250Hong W Chu · National Jewish Health · R01 · FY2017 · HL
Novel function of MUC18: amplification of inflammation in allergic lungs
$396,250Hong W Chu · National Jewish Health · R01 · FY2016 · HL
Novel function of MUC18: amplification of inflammation in allergic lungs
$396,250Hong W Chu · National Jewish Health · R01 · FY2015 · HL
MicroRNA-Based Detection of Barriers to Melanoma Progression
$396,250Robert Laird Judson-Torres · University Of California, San Francisco · DP5 · FY2017 · OD
Function of IL35+ B cells in pancreatic cancer
$396,171Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2024 · CA
Development of a Novel Aqueous Humor-Based Multiplex Assay for Uveal Melanoma Metastatic Risk Prediction
$396,161Liya Xu · Olmeda Biosciences Llc · R41 · FY2024 · CA
RAS dysregulation during HDIL2: a clinical model of sepsis-induced lung injury
$396,103Kevin C Doerschug · University Of Iowa · R56 · FY2015 · HL
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
$396,092Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA